Ipsen today announced that the supplier of Increlex®’s (mecasermin [rDNA origin] Injection) active ingredient, Lonza, is facing manufacturing...
news list
-
25 April 2013 - About Increlex®
-
20 February 2013 - February 27, 2013 : webconference for Ipsen 2012 results
Ipsen will host an analyst meeting on Wednesday, February 27, 2013 at 8:30 a.m. (Paris time, GMT+1).
The webcast will be available live by...
-
16 January 2013 - February 27, 2013: Full year 2012 results
-
31 October 2012 - Webcast and Conference call for financial analysts
Ipsen will host a web conference (audio webcast) and conference call on Wednesday 31 October 2012 at 2:30 pm (Paris time - GMT+1).
The...
-
21 September 2012 - Ipsen and the University of Manchester pursue their research collaboration in genetic studies for children suffering from short stature
- The University of Manchester will conduct further analyses using the anonymous data from Ipsen-sponsored EPIGROW study
- EPIGROW...
-
27 August 2012 - Webcast: Ipsen's half-year 2012 Results
Ipsen will host an analyst meeting on Tuesday 28 August 2012 at 2:00 p.m. (Paris time, GMT+1).
The webcast will be available live by...06 June 2012 - Publication of Ipsen presentation brochure: The Group in 201102 May 2012 - Publication of Ipsen 2011 Registration document29 February 2012 - Full year 2011 resultsIpsen will host an analyst meeting on Wednesday 29 February 2012 at 2:00 p.m. (Paris time, GMT+1) at its...
02 February 2012 - Webcast: fourth quarter and full year 2011 salesIpsen will host a web conference (webcast) and conference call on Thursday 2 February 2012 at 3:00 pm (Paris time - GMT+1).
The webcast...